Citation Impact
1 from Science/Nature 67 standout
Citing Papers
Overall Survival With Palbociclib Plus Letrozole in Advanced Breast Cancer
2024 Standout
Deciphering breast cancer: from biology to the clinic
2023 Standout
Works of M. Campone being referenced
LBA17 Overall survival (OS) results from the phase III MONALEESA-2 (ML-2) trial of postmenopausal patients (pts) with hormone receptor positive/human epidermal growth factor receptor 2 negative (HR+/HER2−) advanced breast cancer (ABC) treated with endocrine therapy (ET) ± ribociclib (RIB)
2021
1LBA Everolimus plus exemestane for hormone receptor-positive (HR+), human epidermal growth factor receptor-2-negative (HER2–) advanced breast cancer (BC): overall survival results from BOLERO-2
2014
Author Peers
| Author | Oncology | PRM | Molecular Biology | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|
| M. Campone | 127 | 85 | 78 | 21 | 214 | |
| Håkan Wedin | 9 | 21 | 9 | 664 | ||
| A. S. Ciampa | 114 | 191 | 260 | 17 | 718 | |
| J. DeFranza | 6 | 10 | ||||
| Lawrence C. Stedman | 5 | 31 | 503 | |||
| Daryl McKee | 26 | 2.7k |
All Works
Loading papers...